Lamotrigine
Product Images NDC 50436-0149

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 50436-0149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (5cd06eba 4ddf 45dc 98d5 D2b79708ab44 01)

Chemical structure of lamotrigine, showing a benzene ring with two chlorine atoms and an amine group, connected to a triazine ring with an amino and methyl groups.*

FDA Label Image

Figure 1 (5cd06eba 4ddf 45dc 98d5 D2b79708ab44 02)

A Kaplan-Meier failure probability survival curve chart comparing Lamotrigine and Placebo groups over approximately 100 weeks. The vertical axis shows failure probability (%) from 0 to 100, and the horizontal axis shows time in weeks. The Placebo group shows higher failure probability across most time points compared to the Lamotrigine group. Censored data points are marked on both curves.*

FDA Label Image

Figure 2 (5cd06eba 4ddf 45dc 98d5 D2b79708ab44 03)

A line graph comparing failure probability (%) over weeks between Lamotrigine and Placebo. The X-axis represents weeks from 0 to 80, and the Y-axis shows failure probability from 0% to 100%. Two lines show trends for Lamotrigine and Placebo, with markers indicating censored data points.*

FDA Label Image

Tablet (5cd06eba 4ddf 45dc 98d5 D2b79708ab44 04)

A printed tablet identification chart for Lamotrigine Tablets showing four different strengths. Each tablet is light pink, debossed with a unique code: 25 mg tablet marked C148, 100 mg tablet marked C149, 150 mg tablet marked C151, and 200 mg tablet marked C152. The image aids visual identification of the tablets by imprint and strength.*

FDA Label Image

Label Image (Lbl504360149)

Package label for Lamotrigine 100 MG, 30 tablets per bottle, labeled by Unit Dose Services. Each scored tablet contains Lamotrigine USP 100mg. Manufactured by Cipla Ltd in Verna, Goa, India. The label includes storage instructions, a warning to keep out of reach of children, and indicates the product is prescription-only (RX ONLY).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.